S&P 500

5.346,99

-0,11%

Negocie como um profissional: Aproveite discussões em tempo real e ideias que movimentam o mercado para superar a concorrência.

Cadastre-se

Início
Investir
Ações
EUA
NASDAQ
Scopus BioPharma Inc (SCPS)
Scopus BioPharma Inc (SCPS) Notícias

SCPS

Scopus BioPharma (SCPS)

Scopus BioPharma Inc

De:

Notícias regulamentadas

Procure um Texto:

Ordenação:

Notícias não regulamentadas

Apresentando as notícias mais relevantes sobre:NASDAQ:SCPS

1 2 3 Próxima >>

Data	Hora	Fonte	Título	Código	Companhia
02/11/2023	10:15	GlobeNewswire Inc.	Scopus BioPharma’s Subsidiary — Duet BioTherapeutics — to Present at the 38th Annual Meeting of the Society for Immunotherapy of Cancer	NASDAQ:SCPS	Scopus BioPharma Inc
28/06/2023	18:16	Edgar (US Regulatory)	Proxy Soliciting Materials (revised) (prer14a)	NASDAQ:SCPS	Scopus BioPharma Inc
12/05/2023	18:16	Edgar (US Regulatory)	Quarterly Report (10-q)	NASDAQ:SCPS	Scopus BioPharma Inc
28/04/2023	18:05	Edgar (US Regulatory)	Amended Annual Report (10-k/a)	NASDAQ:SCPS	Scopus BioPharma Inc
14/04/2023	18:01	Edgar (US Regulatory)	Annual Report (10-k)	NASDAQ:SCPS	Scopus BioPharma Inc
16/12/2022	08:06	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:SCPS	Scopus BioPharma Inc
02/12/2022	19:17	Edgar (US Regulatory)	Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a)	NASDAQ:SCPS	Scopus BioPharma Inc
15/11/2022	19:16	Edgar (US Regulatory)	Notification That Quarterly Report Will Be Submitted Late (nt 10-q)	NASDAQ:SCPS	Scopus BioPharma Inc
10/11/2022	11:15	GlobeNewswire Inc.	Scopus BioPharma’s Subsidiary — Duet BioTherapeutics — Announces Key Scientific Data to be Presented at the 37th Annual Meeting and Exposition of the Society for Immunotherapy of Cancer	NASDAQ:SCPS	Scopus BioPharma Inc
18/10/2022	10:25	GlobeNewswire Inc.	Scopus Biopharma Completes Recapitalization Designed To Enhance Shareholder Value	NASDAQ:SCPS	Scopus BioPharma Inc
05/05/2022	09:30	GlobeNewswire Inc.	Scopus BioPharma Announces Biotechnology Industry Leader Rejoins Board of Directors	NASDAQ:SCPS	Scopus BioPharma Inc
01/04/2022	18:17	Edgar (US Regulatory)	Notification That Annual Report Will Be Submitted Late (nt 10-k)	NASDAQ:SCPS	Scopus BioPharma Inc
22/03/2022	21:30	GlobeNewswire Inc.	Scopus BioPharma’s Subsidiary — Duet BioTherapeutics — to Present at the 3rd Annual STING & TLR-Targeting Therapies Summit	NASDAQ:SCPS	Scopus BioPharma Inc
20/01/2022	10:35	Edgar (US Regulatory)	Prospectus Filed Pursuant to Rule 424(b)(2) (424b2)	NASDAQ:SCPS	Scopus BioPharma Inc
19/01/2022	08:07	Edgar (US Regulatory)	Notice of Effectiveness (effect)	NASDAQ:SCPS	Scopus BioPharma Inc
10/01/2022	10:30	GlobeNewswire Inc.	Scopus BioPharma Provides Update Following Annual Meeting of Stockholders	NASDAQ:SCPS	Scopus BioPharma Inc
10/01/2022	10:01	Edgar (US Regulatory)	Amended Current Report Filing (8-k/a)	NASDAQ:SCPS	Scopus BioPharma Inc
06/01/2022	09:00	PR Newswire (US)	DR. MORRIS C. LASTER WINS PROXY CONTEST AS STOCKHOLDERS ELECT HIS NOMINEES TO SCOPUS BIOPHARMA INC. BOARD OF DIRECTORS	NASDAQ:SCPS	Scopus BioPharma Inc
05/01/2022	18:51	Edgar (US Regulatory)	Additional Proxy Soliciting Materials - Non-management (definitive) (dfan14a)	NASDAQ:SCPS	Scopus BioPharma Inc
04/01/2022	08:05	Edgar (US Regulatory)	Securities Registration Statement (simplified Form) (s-3)	NASDAQ:SCPS	Scopus BioPharma Inc
17/12/2021	10:01	Edgar (US Regulatory)	Additional Proxy Soliciting Materials (definitive) (defa14a)	NASDAQ:SCPS	Scopus BioPharma Inc
17/12/2021	10:00	GlobeNewswire Inc.	Scopus BioPharma Issues Open Letter to Stockholders Detailing Morris Laster’s Campaign Against the Company	NASDAQ:SCPS	Scopus BioPharma Inc
07/12/2021	19:24	Edgar (US Regulatory)	Small Company Offering and Sale of Securities Without Registration (d)	NASDAQ:SCPS	Scopus BioPharma Inc
07/12/2021	10:30	GlobeNewswire Inc.	Scopus BioPharma Sends Letter Urging Stockholders to Vote “FOR ALL” of the Company’s Director Nominees on the WHITE Proxy Card	NASDAQ:SCPS	Scopus BioPharma Inc
06/12/2021	09:00	PR Newswire (US)	Dr. Morris C. Laster Issues An Open Letter To Scopus BioPharma Inc. Stockholders In Connection With Upcoming Annual Meeting	NASDAQ:SCPS	Scopus BioPharma Inc
26/11/2021	19:02	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:SCPS	Scopus BioPharma Inc
22/11/2021	10:00	GlobeNewswire Inc.	Scopus BioPharma Announces $9.75 Million Private Placement Priced At-The-Market	NASDAQ:SCPS	Scopus BioPharma Inc
08/11/2021	10:00	GlobeNewswire Inc.	Scopus BioPharma Announces Adjournment of Annual Meeting of Stockholders	NASDAQ:SCPS	Scopus BioPharma Inc
06/10/2021	16:07	Edgar (US Regulatory)	Proxy Statment - Contested Solicitations (definitive) (defc14a)	NASDAQ:SCPS	Scopus BioPharma Inc
05/10/2021	09:45	GlobeNewswire Inc.	Scopus BioPharma to Present at the LD Micro Main Event	NASDAQ:SCPS	Scopus BioPharma Inc